Polymeric Amorphous Solid Dispersions of Dasatinib: Formulation and Ecotoxicological Assessment
Dasatinib (DAS), a potent anticancer drug, has been subjected to formulation enhancements due to challenges such as significant first-pass metabolism, poor absorption, and limited oral bioavailability. To improve its release profile, DAS was embedded in a matrix of the hydrophilic polymer polyvinylp...
Saved in:
Main Authors: | Katarina Sokač (Author), Martina Miloloža (Author), Dajana Kučić Grgić (Author), Krunoslav Žižek (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib
by: Sathish Dharani, et al.
Published: (2022) -
Advances in the development of amorphous solid dispersions: The role of polymeric carriers
by: Jie Zhang, et al.
Published: (2023) -
Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers
by: Afroditi Kapourani, et al.
Published: (2021) -
Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
by: Gergő Fülöp, et al.
Published: (2018) -
Fluoroquinolone Amorphous Polymeric Salts and Dispersions for Veterinary Uses
by: Hanah Mesallati, et al.
Published: (2019)